Researchers have developed a novel molecular glue, CLEO4-88, capable of selectively dampening the activity of disease-causing proteins. This approach differs from traditional molecular glues by binding to a single protein and inducing a conformational change that enables it to interact with a second protein, rather than marking one for destruction. The method was successfully demonstrated in targeting a protein involved in prostate cancer and a metabolic protein, offering a new therapeutic strategy for previously undruggable targets. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT Offers a new therapeutic strategy for targeting previously undruggable proteins, potentially impacting drug development for cancers and metabolic disorders.
RANK_REASON The cluster describes a scientific paper detailing a new method for drug discovery and a specific molecular glue developed by researchers. [lever_c_demoted from research: ic=1 ai=0.4]
